AIMS: Little is known about how non-problematic drinkers respond to advice to reduce alcohol consumption as part of disease management. In this article, we examine patient reports of drinking behaviour after being diagnosed with chronic hepatitis C, a condition for which alcohol consumption is contraindicated. METHODS: In this qualitative study, we analyzed transcripts of semi-structured interviews with hepatitis C virus+ (HCV+) patients whose level of alcohol consumption would not be considered problematic in the absence of their diagnosis. RESULTS: Most respondents reported some instances of adherence, but only half adhered to the advice to limit drinking consistently over time. Respondents who did not stop drinking often modified their behaviour by changing the type of alcohol consumed or limiting drinking to particular occasions. CONCLUSION: Most informants understood the risks of drinking after HCV infection, particularly in the presence of symptoms, with the onset of complications, or when undergoing treatment. But some believed they could monitor their bodies for evidence of disease progression or that drinking was acceptable during early, asymptomatic stages of infection. Our results also identified situations in which patients need support in adhering to intentions not to drink, including social pressures, stressful situations, or environmental triggers.
AIMS: Little is known about how non-problematic drinkers respond to advice to reduce alcohol consumption as part of disease management. In this article, we examine patient reports of drinking behaviour after being diagnosed with chronic hepatitis C, a condition for which alcohol consumption is contraindicated. METHODS: In this qualitative study, we analyzed transcripts of semi-structured interviews with hepatitis C virus+ (HCV+) patients whose level of alcohol consumption would not be considered problematic in the absence of their diagnosis. RESULTS: Most respondents reported some instances of adherence, but only half adhered to the advice to limit drinking consistently over time. Respondents who did not stop drinking often modified their behaviour by changing the type of alcohol consumed or limiting drinking to particular occasions. CONCLUSION: Most informants understood the risks of drinking after HCV infection, particularly in the presence of symptoms, with the onset of complications, or when undergoing treatment. But some believed they could monitor their bodies for evidence of disease progression or that drinking was acceptable during early, asymptomatic stages of infection. Our results also identified situations in which patients need support in adhering to intentions not to drink, including social pressures, stressful situations, or environmental triggers.
Authors: F Pessione; F Degos; P Marcellin; V Duchatelle; C Njapoum; M Martinot-Peignoux; C Degott; D Valla; S Erlinger; B Rueff Journal: Hepatology Date: 1998-06 Impact factor: 17.425
Authors: Alexander Monto; Keyur Patel; Alan Bostrom; Stephen Pianko; Paul Pockros; John G McHutchison; Teresa L Wright Journal: Hepatology Date: 2004-03 Impact factor: 17.425
Authors: Carol E Blixen; Noah J Webster; Andrew J Hund; Adam T Perzynski; Stephanie W Kanuch; Eleanor Palo Stoller; Richard A McCormick; Neal V Dawson Journal: J Gen Intern Med Date: 2008-08 Impact factor: 5.128
Authors: Eleanor Palo Stoller; Joseph G Grzywacz; Sara A Quandt; Ronny A Bell; Christine Chapman; Kathryn P Altizer; Thomas A Arcury Journal: J Aging Health Date: 2011-02-10
Authors: Adam T Perzynski; Richard McCormick; Noah J Webster; Carol E Blixen; Stephanie Kanuch; Charles L Thomas; Kevin D Mullen; Neal V Dawson Journal: J Stud Alcohol Drugs Date: 2011-09 Impact factor: 2.582
Authors: Lydia N Drumright; Holly Hagan; David L Thomas; Mary H Latka; Elizabeth T Golub; Richard S Garfein; John D Clapp; Jennifer V Campbell; Sebastian Bonner; Farzana Kapadia; Thelma King Thiel; Steffanie A Strathdee Journal: J Hepatol Date: 2010-11-24 Impact factor: 25.083
Authors: Brett Burnham; Sherrie Wallington; Irene A Jillson; Holta Trandafili; Kirti Shetty; Judy Wang; Christopher A Loffredo Journal: Am J Health Behav Date: 2014-09
Authors: Eleanor Palo Stoller; Noah J Webster; Carol E Blixen; Richard A McCormick; Adam T Perzynski; Stephanie W Kanuch; Neal V Dawson Journal: Am J Health Behav Date: 2009 Jul-Aug
Authors: Carol E Blixen; Noah J Webster; Andrew J Hund; Adam T Perzynski; Stephanie W Kanuch; Eleanor Palo Stoller; Richard A McCormick; Neal V Dawson Journal: J Gen Intern Med Date: 2008-01-03 Impact factor: 5.128
Authors: Eleanor Palo Stoller; Noah J Webster; Carol E Blixen; Richard A McCormick; Andrew J Hund; Adam T Perzynski; Stephanie W Kanuch; Charles L Thomas; Kyle Kercher; Neal V Dawson Journal: J Mix Methods Res Date: 2009
Authors: Daniel Fuster; Judith I Tsui; Debbie M Cheng; Emily K Quinn; Carly Bridden; David Nunes; Howard Libman; Richard Saitz; Jeffrey H Samet Journal: Alcohol Clin Exp Res Date: 2013-05-03 Impact factor: 3.455